Cargando…
Opicapone for Parkinson’s disease
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Therapeutic Guidelines
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664095/ http://dx.doi.org/10.18773/austprescr.2023.012 |
_version_ | 1785148698966097920 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10664095 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Therapeutic Guidelines |
record_format | MEDLINE/PubMed |
spelling | pubmed-106640952023-12-05 Opicapone for Parkinson’s disease Aust Prescr New Drug Therapeutic Guidelines 2023-08-22 2023-08 /pmc/articles/PMC10664095/ http://dx.doi.org/10.18773/austprescr.2023.012 Text en (c) Therapeutic Guidelines https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License. |
spellingShingle | New Drug Opicapone for Parkinson’s disease |
title | Opicapone for Parkinson’s disease |
title_full | Opicapone for Parkinson’s disease |
title_fullStr | Opicapone for Parkinson’s disease |
title_full_unstemmed | Opicapone for Parkinson’s disease |
title_short | Opicapone for Parkinson’s disease |
title_sort | opicapone for parkinson’s disease |
topic | New Drug |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664095/ http://dx.doi.org/10.18773/austprescr.2023.012 |